Express Scripts Holding Company (ESRX) Shares Sold by BlueCrest Capital Management Ltd
BlueCrest Capital Management Ltd lowered its position in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 49.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,868 shares of the company’s stock after selling 17,255 shares during the period. BlueCrest Capital Management Ltd’s holdings in Express Scripts Holding were worth $1,178,000 as of its most recent filing with the SEC.
Several other hedge funds have also modified their holdings of the stock. Hancock Holding Co. increased its stake in shares of Express Scripts Holding by 9.9% in the first quarter. Hancock Holding Co. now owns 183,489 shares of the company’s stock worth $12,094,000 after buying an additional 16,536 shares during the period. Twin Capital Management Inc. increased its stake in shares of Express Scripts Holding by 0.8% in the first quarter. Twin Capital Management Inc. now owns 46,560 shares of the company’s stock worth $3,069,000 after buying an additional 360 shares during the period. Van ECK Associates Corp increased its stake in shares of Express Scripts Holding by 28.8% in the first quarter. Van ECK Associates Corp now owns 373,636 shares of the company’s stock worth $24,626,000 after buying an additional 83,568 shares during the period. ACR Alpine Capital Research LLC increased its stake in shares of Express Scripts Holding by 6.3% in the first quarter. ACR Alpine Capital Research LLC now owns 1,463,799 shares of the company’s stock worth $96,479,000 after buying an additional 87,292 shares during the period. Finally, Wilkins Investment Counsel Inc. increased its stake in shares of Express Scripts Holding by 6.9% in the first quarter. Wilkins Investment Counsel Inc. now owns 118,336 shares of the company’s stock worth $7,800,000 after buying an additional 7,630 shares during the period. Hedge funds and other institutional investors own 90.20% of the company’s stock.
Shares of Express Scripts Holding Company (ESRX) traded up 0.05% during trading on Tuesday, hitting $62.35. The company had a trading volume of 327,103 shares. The stock has a market capitalization of $36.01 billion, a P/E ratio of 10.82 and a beta of 0.90. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.61. The firm’s 50 day moving average is $63.15 and its 200-day moving average is $64.92.
Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. During the same period in the prior year, the company earned $1.57 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Equities research analysts anticipate that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Express Scripts Holding Company (ESRX) Shares Sold by BlueCrest Capital Management Ltd” was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/08/08/express-scripts-holding-company-esrx-shares-sold-by-bluecrest-capital-management-ltd.html.
A number of analysts have recently issued reports on ESRX shares. ValuEngine downgraded Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Mizuho dropped their price target on Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating for the company in a research report on Tuesday, April 25th. Needham & Company LLC started coverage on Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating for the company. Cowen and Company reiterated an “outperform” rating and set a $83.00 price target on shares of Express Scripts Holding in a research report on Friday, June 9th. Finally, Evercore ISI dropped their price target on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research report on Wednesday, April 26th. Four investment analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Express Scripts Holding has an average rating of “Hold” and an average price target of $70.81.
In related news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at $667,368.64. The sale was disclosed in a filing with the SEC, which is available through this link. 0.68% of the stock is currently owned by corporate insiders.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.